For any custom sample collection or services inquiries, please call us at 301-417-4343 to Learn more!

Human Tissue Microarray (MT065-01H)

Multiple organ tumor tissue microarray with 64 cases of different tumor types, 1 core per case.
$250.00
More Information
Species Human
Section Thickness 5 µm
Fixative Formalin
Total Cases 64
Total Cores 65
Core Diameter 1.5 mm
Storage Short term RT
Usage For research use only. Designed for Immunohistochemistry (IHC) and In Situ Hybridization (ISH)
USBIOLAB
  • A
  • AD
  • AD
  • AD
  • AD
  • AD
  • AD
  • AD
  • AD
  • AD
  • AD
  • B
  • AD
  • AD
  • AD
  • AD
  • AD
  • AD
  • AD
  • AD
  • AD
  • AD
  • C
  • AD
  • AD
  • AD
  • AD
  • AD
  • AD
  • AD
  • AD
  • AD
  • AD
  • D
  • AD
  • AD
  • AD
  • AD
  • AD
  • AD
  • AD
  • AD
  • AD
  • AD
  • E
  • AD
  • AD
  • AD
  • AD
  • AD
  • AD
  • AD
  • AD
  • AD
  • AD
  • F
  • AD
  • AD
  • AD
  • AD
  • AD
  • AD
  • AD
  • AD
  • AD
  • AD
  • G
  • AD
  • AD
  • AD
  • AD
  • AD
  • AD
  • AD
  • AD
  • AD
  • AD
No. Map ID Age Sex Organ Pathology Diagnosis Grade TNM Stage Type Block ID
1
A1
50
F
Adrenal gland
Adenoma
G2
T2N1M0
II
Benign
1-6872
2
A2
32
F
Adrenal gland
Pheochromocytoma
G2
T2N3M0
III
Malignant
1/24122
3
A3
50
M
Appendix
Carcinoid tumor
G1
T3N0M0
-
Malignant
AP 04
4
A4
56
M
Bladder
Squamous cell carcinoma
G2
T2N2M0
IIIA
Malignant
1/1141
5
A5
50
M
Bladder
Urothelial cell carcinoma
-
T4N2M0
III
Malignant
9681A1/22
6
A6
75
M
Bone
Plasmacytoma
-
-
-
Malignant
1/17048
7
A7
75
F
Breast
Ductal carcinoma in situ (DCIS)
G2
T2N1M0
-
Benign
U1912101
8
A8
80
F
Breast
Invasive ductal carcinoma (ER+, PR+, HER2 -)
G3
-
-
Malignant
CNC003/21
9
A9
66
F
Breast
Invasive lobular carcinoma (ER+, PR-, HER2+)
G3
T2N1aM0
-
Malignant
CNC1749/19
10
A10
-
-
Blank
Blank
-
-
-
-
-
11
B1
40
F
Brain,Cerebellum
Oligodendroglioma
-
-
-
Malignant
B-2066-17-002-003
12
B2
48
M
Brain,Cerebrum
Ependymoma
G2
-
-
Malignant
1/18347
13
B3
67
F
Brain,Cerebrum
Glioblastoma
G4
-
-
Malignant
2018-20302C
14
B4
60
F
Brain,Cerebrum
Meningioma
-
-
-
Malignant
B-19-10555-001-005
15
B5
46
F
Cervix
Adenocarcinoma
-
T1bN1M0
IB
Malignant
B-4607-17-001-005
16
B6
53
F
Cervix
Squamous cell carcinoma
G2
T2bN1M0
IIIB
Malignant
21112037A
17
B7
57
M
Colon
Adenocarcinoma
G2
T3N0M0
IIA
Malignant
21112145A
18
B8
68
M
Colon
Adenosquamous carcinoma
G2
T3N0M0
IIA
Malignant
CRC-2012120
19
B9
51
M
Esophagus
Adenocarcinoma
G1
-
-
Malignant
21111895A
20
B10
68
F
Esophagus
Squamous cell carcinoma
G3
T3N1M0
III
Malignant
21112209A
21
C1
63
M
Head and neck
Adenocarcinoma
-
T4aN0M0
IVA
Malignant
B-215-17-001-001
22
C2
53
M
Head and neck
Squamous cell carcinoma
G1
T3N2M0
IVA
Malignant
21112124A
23
C3
54
M
Kidney
Papillary renal adenoma
G2
T2N0M0
II
Benign
1/23380
24
C4
47
M
Kidney
Renal cell carcinoma
G1
T1bN0M0
-
Malignant
21113371A
25
C5
63
M
Liver
Cholangiocarcinoma
G2
T3N0M0
IIIa
Malignant
21112198A
26
C6
61
M
Liver
Hepatocellular carcinoma
G1
-
-
Malignant
21110733A
27
C7
29
M
Lymph node
Anaplastic large cell lymphoma
-
-
-
Malignant
21115413A
28
C8
50
M
Lymph node
Follicular lymphoma
-
-
-
Malignant
H19/1248
29
C9
34
M
Lymph node
Hodgkin's lymphoma
-
-
-
Malignant
H19/8766
30
C10
-
-
Blank
Blank
-
-
-
-
-
31
D1
59
M
Lung
Adenocarcinoma
G2
-
-
Malignant
21117745A
32
D2
57
M
Lung
Squamous cell carcinoma
G1
T2N0M0
IB
Malignant
21110161D
33
D3
58
M
Lung
Small cell lung carcinoma
-
-
IIA
Malignant
F18-05481
34
D4
62
F
Mesothelium
Mesothelioma
-
T2N1M0
II
Malignant
B-18-78-002-003
35
D5
56
F
Mesothelium
Pleural solitary fibrous tumor
-
-
-
Malignant
B/5253/15 A2
36
D6
47
F
Muscle
Alveolar rhabdomyosarcoma
-
T2N1M0
IV
Malignant
B-10593-16-001-012
37
D7
32
F
Muscle
Myxoma
G2
T2N1M0
-
Benign
1/13085
38
D8
37
F
Ovary
Granulosa cell tumor
G2
T2N2M0
-
Malignant
1/886
39
D9
57
F
Ovary
Serous carcinoma
G1
T3N1M1
IV
Malignant
21112634A
40
D10
25
F
Ovary
Teratoma
G3
T3N2M0
III
Benign
1/15043
41
E1
73
M
Pancreas
Islet cell tumor
G2
T3N0M0
II
Malignant
PAN-2012038
42
E2
63
M
Pancreas
Pancreatic ductal adenocarcinoma
G2
T3N0M0
IIA
Malignant
1506540-M
43
E3
58
M
Peripheral nerve
Neurofibrosarcoma
G3
-
-
Malignant
B/629/12 A7
44
E4
45
F
Peripheral nerve
Schwannoma
G2
T2N1M0
II
Benign
1-4319
45
E5
76
M
Prostate
Adenocarcinoma (Gleason Score 5+4)
-
-
-
Malignant
2008-8901B
46
E6
75
M
Prostate
Adenocarcinoma (Gleason Score 4+3)
-
-
-
Malignant
2015-5066M
47
E7
28
M
Salivary gland
Pleomorphic adenoma
G2
T2N2M0
II
Benign
1-5511
48
E8
50
M
Salivary gland
Warthin's tumor
G2
T2N2M0
II
Benign
1-5428
49
E9
71
M
Small intestine
Adenocarcinoma
G2
-
-
Malignant
21111790A
50
E10
51
M
Small intestine
Gastrointestinal stromal tumor (GIST)
-
T4N0M0
IIIB
Malignant
B/8947/14 A3
51
F1
77
F
Soft Tissue
Angiosarcoma
-
T1N0M0
IA
Malignant
B-1782-17-004-003
52
F2
30
F
Soft Tissue
Liposarcoma
G3
T2N0M0
-
Malignant
21113684A
53
F3
45
F
Spleen
Diffuse large B-cell lymphoma
-
-
II
Malignant
DLBCL-2012008-3C
54
F4
63
F
Stomach
Adenocarcinoma
G3
T4N2M0
IIIA
Malignant
21112006A
55
F5
54
F
Stomach
Gastrointestinal stromal tumor (GIST)
G2
T2N2M0
-
Malignant
1-8506
56
F6
37
M
Testis
Embryonal carcinoma
G2
T3N2M0
IIB
Malignant
TEC-2310001
57
F7
43
M
Testis
Seminoma
-
T2N0M0
-
Malignant
21115452A
58
F8
57
F
Thyroid
Follicular thyroid cancer
G2
T3aN0M0
III
Malignant
1-5053
59
F9
60
F
Thyroid
Papillary thyroid cancer
-
T2N0M0
-
Malignant
21113237A
60
F10
-
-
Blank
Blank
-
-
-
-
-
61
G1
60
F
Uterus
Clear cell carcinoma
G2
T2bN0M0
II
Malignant
1-3655
62
G2
56
F
Uterus
Endometrioid carcinoma
G1
T2aN1M0
-
Malignant
21112779A
63
G3
34
F
Uterus
Leiomyoma
G2
T2N3M0
II
Benign
1-22636
64
G4
52
F
Uterus
Leiomyosarcoma
-
T2aN0M0
IIA
Malignant
B-4560-16-001-011
65
G5
66
M
Skin
Basal cell carcinoma
-
T2N0M0
II
Malignant
B-17-9521-001-001
66
G6
51
F
Skin
Invasive melanoma
-
-
-
Malignant
MD 45652/20
67
G7
57
M
Skin
Squamous cell carcinoma
-
T2N0M0
II
Malignant
B-352-17-001-001
68
G8
-
-
Blank
Blank
-
-
-
-
-
69
G9
-
-
Blank
Blank
-
-
-
-
-
70
G10
-
-
Tonsil
Tissue Marker
-
-
-
-
147/17